| | | Copy number loss | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant +1 more) | Hereditary cancer-predisposing syndrome +1 more | |
| | LOC129390903, RAD51C (H233fs) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | LOC129390903, RAD51C (H233fs) | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Indel (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | LOC129390903, RAD51C (L219fs) | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | LOC129390903, RAD51C (S206fs) | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Indel (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | LOC129390903, RAD51C (Y210*) | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Deletion (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | LOC129390903, RAD51C (Y209*) | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Indel (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (splice acceptor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | GPathogenic/Likely pathogenic |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | LOC129390903, RAD51C (D228N) | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +1 more | |
| | | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (splice acceptor variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Copy number loss | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Duplication (frameshift variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (intron variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +1 more | |
| | | Duplication (frameshift variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Deletion (frameshift variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Deletion (splice donor variant) | Fanconi anemia complementation group O +1 more | |
| | LOC129390903, RAD51C (S206fs) | Microsatellite (frameshift variant +1 more) | Fanconi anemia complementation group O +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion (splice donor variant) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Duplication (nonsense +2 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (missense variant +1 more) | Hereditary cancer-predisposing syndrome +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +2 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | Hereditary cancer-predisposing syndrome +2 more | |
| | | Single nucleotide variant (nonsense) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Deletion (splice donor variant) | Hereditary cancer-predisposing syndrome +1 more | |
| | | Single nucleotide variant (nonsense) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Deletion (genic downstream transcript variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (5 prime UTR variant +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 | |
| | | Single nucleotide variant (3 prime UTR variant +2 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +2 more | GConflicting classifications of pathogenicity |
| | | Deletion (frameshift variant +1 more) | Fanconi anemia complementation group O +1 more | GPathogenic/Likely pathogenic |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +2 more | |
| | | Duplication (frameshift variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Duplication (frameshift variant) | Breast-ovarian cancer, familial, susceptibility to, 3 +1 more | |
| | | Insertion (frameshift variant +1 more) | Fanconi anemia complementation group O +2 more | |
| | | Single nucleotide variant (missense variant) | Fanconi anemia complementation group O +2 more | |
| | | Deletion (frameshift variant +1 more) | Fanconi anemia complementation group O +1 more | GPathogenic/Likely pathogenic |
| | | Single nucleotide variant (missense variant +1 more) | Fanconi anemia complementation group O +1 more | |
| | | Single nucleotide variant (intron variant) | Fanconi anemia complementation group O +1 more | GConflicting classifications of pathogenicity |
| | | Single nucleotide variant (nonsense +1 more) | Breast-ovarian cancer, familial, susceptibility to, 3 +2 more | |
| | | Deletion | Breast-ovarian cancer, familial, susceptibility to, 3 | |